Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Wandl

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|April 20, 1990
[Cardiac side effects of 5-fluorouracil]D May, U Wandl, R Becher, et al.
Leukemia|June 1, 1991
Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapyB Opalka, U Wandl, U Beer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cellsW Dempke, P Nehls, U Wandl, et al.
Seminars in Oncology|June 1, 1987
Interferon alfa-2b in the treatment of chronic myelogenous leukemiaN Niederle, O Kloke, R Osieka, et al.
Blut|July 1, 1990
Treatment of chronic myelogenous leukemia with interferons alpha and gammaO Kloke, D May, U Wandl, et al.
Blood|February 15, 1989
A PvuII polymorphism of the bcr region in patients with hematopoietic disorders and their familiesB Opalka, U Wandl, O Kloke, et al.
Experimental Hematology|October 1, 1984
Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytesJ S Greenberger, A M Krensky, H Messner, et al.
Deutsche Medizinische Wochenschrift (1946)|December 19, 1986
[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide]H Höfeler, K Höffken, N Niederle, et al.
Seminars in Oncology|February 1, 1989
Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancerR Becher, H Höfeler, O Kloke, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patientsN Niederle, T Moritz, O Kloke, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|April 20, 1990
[Cardiac side effects of 5-fluorouracil]D May, U Wandl, R Becher, et al.
Leukemia|June 1, 1991
Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapyB Opalka, U Wandl, U Beer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1987
Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cellsW Dempke, P Nehls, U Wandl, et al.
Seminars in Oncology|June 1, 1987
Interferon alfa-2b in the treatment of chronic myelogenous leukemiaN Niederle, O Kloke, R Osieka, et al.
Blut|July 1, 1990
Treatment of chronic myelogenous leukemia with interferons alpha and gammaO Kloke, D May, U Wandl, et al.
Blood|February 15, 1989
A PvuII polymorphism of the bcr region in patients with hematopoietic disorders and their familiesB Opalka, U Wandl, O Kloke, et al.
Experimental Hematology|October 1, 1984
Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytesJ S Greenberger, A M Krensky, H Messner, et al.
Deutsche Medizinische Wochenschrift (1946)|December 19, 1986
[Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide]H Höfeler, K Höffken, N Niederle, et al.
Seminars in Oncology|February 1, 1989
Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancerR Becher, H Höfeler, O Kloke, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon alfa-2b in acute- and chronic-phase chronic myelogenous leukaemia: initial response and long-term results in 54 patientsN Niederle, T Moritz, O Kloke, et al.
Pageof 3